The 2020 National Health Care Drug Negotiations Directory was officially released

The following is the text: Medical Security Bureau of the Production and Construction Corps of the provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang, and the Office of Human Resources and Social Security (the Bureau): In order to implement the Opinions on Deepening the Reform of the Medical Security System issued by the Central Committee of the Communist Party of China and the State Council, in accordance with the Interim Measures for the Administration of Drug Use of Basic Medical Insurance and the State in 2020 The Work Programme for the Adjustment of the Medical Insurance Drug Catalog, and the National Health Insurance Administration and the Ministry of Human Resources and Social Security have organized experts to adjust and develop the National List of Medicines for Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance (2020) (hereinafter referred to as the 2020 Drug Catalog), which is he hedding and is subject to implementation.
relevant matters are notified as follows: First, the 2020 Drug Catalog constitutes the 2020 Drug Catalog containing a total of 2800 western medicine and Chinese medicine, of which 1264 kinds of Western medicine, 1315 kinds of Chinese medicine part, 221 kinds of drugs negotiated during the agreement period.
, there are 892 Chinese medicine tablets that the fund can pay for.
. Strengthen the management of drug payment All localities shall strictly implement the 2020 Drug Catalog, shall not make their own catalogues or use adapted methods to increase the number of drugs in the catalogue, and shall not adjust the limited payment scope of drugs in the catalogue on their own.
timely adjustment of the information system, update and improve the database, the adjustment of the drugs transferred into the fund in accordance with the provisions into the scope of payment, the transferred drugs to be transferred out of the fund payment scope.
the negotiation of medicines (hereinafter referred to as negotiated drugs) during the period of the agreement shall implement the unified national standards for payment of medical insurance, and the co-ordination areas shall determine their out-of-payment ratio and reimbursement ratio according to the affordability of the fund, and no secondary bargaining shall be held during the agreement period.
the medical insurance payment standards in the 2020 Drug Catalog are marked with a "
, do a good job of catalog landing "2020 Drug Catalog" from March 1, 2021 to formally implement.
provinces (districts, cities) drug centralized procurement agencies should negotiate drugs as soon as possible in the provincial drug centralized procurement platform directly online procurement.
drug with the generic name is listed during the period of the agreement, the direct network price of the generic name drug shall not be higher than the standard of payment for medical insurance of the same specification as determined in the negotiation.
specifications and negotiated drugs, the direct internet price is not higher than the standard of medical insurance payment calculated according to the principle of differential price.
provincial health insurance departments may, after the same generic name drug network, formulate a unified standard of medical insurance payment for all drugs under the generic name in accordance with the provisions.
health insurance departments in various places shall, in conjunction with the relevant departments, guide the designated medical institutions to reasonably equip and use the drugs in the catalogue, and may make reasonable adjustments to their annual totals in the light of the actual drug use situation of medical institutions.
strengthen the agreement management of fixed-point medical institutions, and incorporate the rational provision of medical institutions with the use of drugs in the 2020 Drug Catalog into the contents of the agreement.
innovative way of working, through improving the outpatient protection policy, opening the channel of fixed-point pharmacies for medical insurance, reasonable adjustment of total control and other ways to promote the "2020 Drug Catalog" landing.
all localities should establish and improve the monitoring system for the landing of negotiated medicines, and regularly provide feedback to the National Health Insurance Administration as required on the use and payment of medicines in the 2020 Drug Catalog.
provincial health insurance departments should speed up the digestion of the original self-replenishing varieties, clean up the varieties that do not meet the requirements of the Interim Measures for the Administration of Basic Medical Insurance, and promote the basic unification of the scope of drug use.
The Notice of the National Health Insurance Administration, the Ministry of Human Resources and Social Security on the Issue of the National List of Medicines for Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance (Medical Insurance No. 46 of 2019) and the National Health Insurance Administration, the Ministry of Human Resources and Social Security on the Notice for the inclusion of drugs in the national list of essential medical insurance, work injury insurance and maternity insurance drugs in 2019 (Medical Insurance No. 65 of 2019), which shall be repealed simultaneously from March 1, 2021.
, the 17 drugs negotiated for 2018 will still be paid for by the Fund as originally planned.
the implementation of the 2020 Drug Catalog, the State Health Insurance Administration and the Ministry of Human Resources and Social Security shall be reported to the State Health Insurance Administration and the Ministry of Human Resources and Social Security in a timely manner in the event of major problems.
。